Hassan.

الله يجيب ذاك اليوم اليّ اقول فيه .. بعد الصبر نال قلبي مابغى❤️

تعرف على مستقبل اقتصاديات الدواء في السعودية! ورشة عمل مقدمة من @sa_ispor في #Crossroads26. سجل الآن: crossroads.eventregister.app/guest-register

يا بلادي عاد عيدك يا بلادي يا مغنّ المجد والتاريخ كلّه #عيّدي_معتزة #وزارة_الدفاع

لله در اللغة والمفردات التاريخية للتوجيه الملكي: 1- نسميهم الأشقاء محبة وتقديراً. 2- ليست الاستضافة فقط بل والإكرام! 3- لراحتهم بين "أهلهم" لاحظ أهلهم! 4- سالمين معززين مكرمين. 5- تنفيذ ذلك في الحال!

تعلن جمعية اقتصاديات الدواء والمخرجات الصحية عن توقيع مذكرة تفاهم مع
الإدارة العامة للرعاية الصيدلية – وزارة الصحة 🇸🇦
وذلك على هامش مؤتمر ( IHOP 7 ايهوب ٧)، المؤتمر السنوي للإدارة العامة للرعاية الصيدلية. The Pharmacoeconomics and Outcomes Research Society signed a Memorandum of Understanding (MoU) with the
General Administration of Pharmaceutical Care – Ministry of Health, Saudi Arabia,
during the IHOP 7 Conference. 
#IHOP7 #وزارة_الصحة #MinistryOfHealth

We are excited to share the findings of a pivotal pilot study recently published in ClinicoEconomics and Outcomes Research, which establishes a new Multi-Criteria Decision Analysis (MCDA) tool for procuring generic and biosimilar medications in Saudi Arabia.   The Shift to Value-Based Procurement For years, the debate in pharmaceutical procurement has often centered on price. However, this study challenges the "cheapest is best" mindset, aiming to improve spending efficiency while ensuring high-quality patient care. Key Findings from the Study In a workshop involving 49 key stakeholders—including regulators, pharmacists, and health economists—16 essential criteria for procurement were identified and ranked. The results reveal a distinct "Quality-First" approach:   Efficacy Leads the Way: The most critical factor identified was Published Effectiveness Data (11.56%), highlighting a strong demand for peer-reviewed evidence.   Beyond Price: Surprisingly, Direct Costs (7.08%) ranked 6th. Stakeholders prioritized clinical integrity, placing higher weight on Drug Delivery Systems (8.84%), Bioequivalence (7.56%), and Drug Stability (7.26%) over immediate acquisition costs.   Regulatory Trust: Pharmacovigilance received a lower weight (3.23%), reflecting high confidence in the Saudi Food and Drug Authority’s (SFDA) rigorous safety enforcement.   Why This Matters This MCDA tool serves as a foundation for a national value-based procurement system aligned with Saudi Vision 2030. By differentiating between verified clinical effectiveness and simple market data, this framework ensures that public tenders prioritize therapeutic assurance and supply reliability over macroeconomic benefits or low prices. Hana AlAbdulkarim, Yazed Alruthia, Bander Balkhi,Mohammed Almuqbil, Abdulaali Almutairi, Omar Almohammed, Mai Alsaqa’aby, Horiyah Alhajri #HealthcareInnovation #SaudiVision2030 #ValueBasedHealthcare #Pharmacoeconomics #MCDA #PatientSafety #Procurement 

🔗 Full article: dovepress.com/creating-a-mul…

تعلن جمعية اقتصاديات الدواء والمخرجات الصحية عن فتح باب التقديم على وظيفة سكرتير تنفيذي (دوام جزئي، عن بُعد) 🔹 مهام الوظيفة: تنظيم الاجتماعات، إعداد المراسلات، حفظ الوثائق الرسمية، المساعدة في المهام الإدارية والمالية، ودعم أعمال اللجان والفعاليات. 🔹 العمل: دوام جزئي، عن بُعد 📎 للتقديم عبر النموذج: forms.gle/nps6VQULfM8U6g… #وظائف #وظائف_إدارية #وظائف_عن_بعد #PEORSociety #PEOR25

#مجلس_الوزراء: قيام وزارة الصناعة والثروة المعدنية بالاتفاق مع وزارة المالية؛ لاتخاذ ما يلزم لاستحداث واعتماد بند خاص بتوطين الصناعات الدوائية في ميزانيات الجهات الصحية الحكومية. #واس

A highlight recap from the first day of The 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference, featuring key moments, sessions, and expert discussions advancing health economics and outcomes research in Saudi Arabia. 📅 2 November 2025 📍 Hiwar Hall – King Abdulaziz Center for Cultural Communication – Riyadh Continue joining us for upcoming day: tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25

The wait is over — the official agenda of the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference, titled “Navigating Healthcare Reform in Saudi Arabia,” is now revealed! Over two days, world-class experts, policy leaders, and researchers will come together to explore how innovation, economics, and evidence-based decision-making are transforming Saudi Arabia’s healthcare system. From health technology assessment and reimbursement models to AI, patient safety, and real-world evidence — this year’s program sets a new benchmark for excellence and collaboration in the region. 📅 2–3 November 2025 📍 King Abdulaziz Center for Cultural Communication – Riyadh Be part of the most impactful health economics event in the Kingdom. 📄 View the full agenda: drive.google.com/file/d/1-2Oytq… Register now to secure your seat: 🔗 tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25 #Vision2030 #SaudiHealth #HealthcareTransformation #HealthEconomics #Pharma #Innovation

Part of the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference titled, “Navigating Healthcare Reform in Saudi Arabia.” Session 4: Privatizing Healthcare Services As Saudi Arabia advances toward its Vision 2030 objectives, privatization remains a cornerstone of the national healthcare transformation, driving efficiency, innovation, and sustainability. This session will bring together key experts to discuss the evolution of privatization models, partnerships, and strategies that empower healthcare institutions to achieve operational excellence. 📅 November 2, 2025 | 3:05–4:35 PM 📍 Hiwar Hall, King Abdulaziz Center for Cultural Communication – Riyadh Be part of this strategic discussion, Register now: tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25 #Vision2030 #SaudiHealth #HealthcareTransformation #PrivateSector #Innovation #Pharma #HealthInsurance

The 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference Session 2 – Private Healthcare Sector Theme: Healthcare System in Saudi Arabia: Past, Present, and Future As Saudi Arabia moves forward under Vision 2030, the private sector plays an essential role in advancing healthcare quality, access, and innovation. Join our experts as they discuss how insurance frameworks, private hospitals, and public–private partnerships (PPPs) are enhancing the Kingdom’s healthcare system. 📅 November 2, 2025 | 10:00–11:30 AM 📍 Hiwar Hall, King Abdulaziz Center for Cultural Communication – Riyadh Don’t miss this important session! tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25 #Vision2030 #SaudiHealth #HealthcareTransformation #PrivateSector #Innovation #Pharma #HealthInsurance

👥 Organizing Committee – 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference A dedicated team working behind the scenes to make this year’s conference a success. 🗓 November 2–3, 2025 📍 Hiwar Hall, King Abdulaziz Center for Cultural Communication – Riyadh Register now to attend the conference: tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25

انطلاق المؤتمر السنوي الخامس لاقتصاديات الدواء بالرياض @sa_ispor لمواكبة إصلاحات الرعاية الصحية في رؤية 2030 #كبسولة_الصحية capsulah.com/18895/

Join the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference. Shape the future of pharmacoeconomics and outcomes research. 🗓 November 2–3, 2025 📍 King Abdulaziz Center for Cultural Communication, Riyadh Register: tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25

Registration is NOW OPEN! Join us at the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference 📅 2–3 November 2025 📍 Hiwar Hall, King Abdulaziz Center for Cultural Communication – Riyadh Don’t miss the chance to be part of inspiring discussions, workshops, and competitions that shape the future of healthcare economics and outcomes research! 🌍✨ 🔗: regs.executechnology.net/peor/register.… #ISPOR_Saudi25 #PEOR25

أصبح التسجيل متاحًا الآن للمؤتمر السنوي الخامس للجمعية السعودية لاقتصاديات الدواء والمخرجات الصحية. انضموا إلينا في هذا الحدث العلمي البارز، حيث تُطرح أبرز المستجدات ويُناقش مستقبل اقتصاديات الصحة وصناعة القرار الصحي. 📅 2–3 نوفمبر 2025 📍قاعة حوار – مركز الملك عبدالعزيز للتواصل الحضاري 🔗 سارعوا بالتسجيل لتأكيد حضوركم. tinyurl.com/peor2025 #ISPOR_Saudi25 #PEOR25

Volunteering at the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference isn’t just giving time, it’s gaining experiences, friendships, and purpose. Join the journey! 🌍 #ISPOR_Saudi25 #PEOR25

Shine a light on your research! Abstract submissions are still open for the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference. Take this chance to present your work and engage with experts and colleagues in pharmacoeconomics and outcomes research. ⏳Last Call. Deadline: September 25th Don’t miss out, send in your abstract before the deadline 🔗 forms.gle/VaSGMLemYyjcxT… #ISPOR_Saudi25 #PEOR25

🏆 في المؤتمر السنوي الخامس للجمعية السعودية لاقتصاديات الدواء والمخرجات الصحية، نحتفي بالتميز! جوائز المؤتمر ستُمنح تقديرًا للأبحاث المميزة التي تسهم في تطوير السياسات الصحية وتحسين نتائج الرعاية. قدّم بحثك الأن: forms.gle/VaSGMLemYyjcxT… #ISPOR_Saudi25 #PEOR25

🌟 Volunteering is more than a role, it’s a journey! Join us on the road to the 5th Annual Saudi Pharmacoeconomics and Outcomes Research Conference 🚀 Your chance to contribute, connect, and shine. forms.gle/yaDpc7JdBgZio7… #ISPOR_Saudi25 #PEOR25